167 related articles for article (PubMed ID: 20195528)
1. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.
Kugelberg E; Gollan B; Farrance C; Bratcher H; Lucidarme J; Ibarz-Pavón AB; Maiden MC; Borrow R; Tang CM
PLoS One; 2010 Feb; 5(2):e9413. PubMed ID: 20195528
[TBL] [Abstract][Full Text] [Related]
2. Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Kugelberg E; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Tang CM; Borrow R
J Clin Microbiol; 2009 Nov; 47(11):3577-85. PubMed ID: 19759227
[TBL] [Abstract][Full Text] [Related]
3. Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
Cayrou C; Akinduko AA; Mirkes EM; Lucidarme J; Clark SA; Green LR; Cooper HJ; Morrissey J; Borrow R; Bayliss CD
PLoS One; 2018; 13(5):e0197186. PubMed ID: 29847547
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease.
Harris SL; Zhu D; Murphy E; McNeil LK; Wang X; Mayer LW; Harrison LH; Jansen KU; Anderson AS
Hum Vaccin; 2011; 7 Suppl(Suppl):68-74. PubMed ID: 21245657
[TBL] [Abstract][Full Text] [Related]
5. A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.
Uria MJ; Zhang Q; Li Y; Chan A; Exley RM; Gollan B; Chan H; Feavers I; Yarwood A; Abad R; Borrow R; Fleck RA; Mulloy B; Vazquez JA; Tang CM
J Exp Med; 2008 Jun; 205(6):1423-34. PubMed ID: 18504306
[TBL] [Abstract][Full Text] [Related]
6. Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.
Green LR; Lucidarme J; Dave N; Chan H; Clark S; Borrow R; Bayliss CD
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950334
[TBL] [Abstract][Full Text] [Related]
7. Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
Marjuki H; Chang HY; Topaz N; Whaley MJ; Vuong J; Chen A; Jenkins LT; Hu F; Schmink S; Retchless AC; Thomas JD; Acosta AM; McNamara LA; Soeters HM; Mbaeyi S; Wang X
mBio; 2021 May; 12(3):. PubMed ID: 34006659
[TBL] [Abstract][Full Text] [Related]
8. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
[TBL] [Abstract][Full Text] [Related]
9. Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
Honskus M; Krizova P; Okonji Z; Musilek M; Kozakova J
PLoS One; 2023; 18(3):e0282971. PubMed ID: 36913385
[TBL] [Abstract][Full Text] [Related]
10. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
11. Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).
Bettinger JA; Liberator P; Halperin SA; Vaudry W; Sadarangani M; Hao L; Lambert N; Jansen KU; Anderson AS; Tsang R;
Vaccine; 2020 Feb; 38(8):2026-2033. PubMed ID: 31983586
[TBL] [Abstract][Full Text] [Related]
12. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
[TBL] [Abstract][Full Text] [Related]
13. Molecular surveillance of brazilian meningococcal isolates serogroup c in the pre and post-men-c-vaccination period: Emergence of ST-3780.
Azevedo AC; Franco NEC; de Carvalho Rocha MR; Andrade C; Torres MC; de Filippis I
Infect Genet Evol; 2020 Mar; 78():104079. PubMed ID: 31669441
[TBL] [Abstract][Full Text] [Related]
14. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
[TBL] [Abstract][Full Text] [Related]
15. Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?
Lucidarme J; Lekshmi A; Parikh SR; Bray JE; Hill DM; Bratcher HB; Gray SJ; Carr AD; Jolley KA; Findlow J; Campbell H; Ladhani SN; Ramsay ME; Maiden MCJ; Borrow R
J Infect; 2017 Aug; 75(2):95-103. PubMed ID: 28579305
[TBL] [Abstract][Full Text] [Related]
16. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.
Lucidarme J; Hill DM; Bratcher HB; Gray SJ; du Plessis M; Tsang RS; Vazquez JA; Taha MK; Ceyhan M; Efron AM; Gorla MC; Findlow J; Jolley KA; Maiden MC; Borrow R
J Infect; 2015 Nov; 71(5):544-52. PubMed ID: 26226598
[TBL] [Abstract][Full Text] [Related]
17. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
[TBL] [Abstract][Full Text] [Related]
18. Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.
Rojas E; Hoyos J; Oldfield NJ; Lee P; Flint M; Jones CH; Ala'Aldeen DA; Jansen KU; Anderson AS
PLoS One; 2015; 10(7):e0132140. PubMed ID: 26147212
[TBL] [Abstract][Full Text] [Related]
19. Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococcal B vaccines.
Terranova L; Principi N; Bianchini S; Di Pietro G; Umbrello G; Madini B; Esposito S
Hum Vaccin Immunother; 2018 May; 14(5):1070-1074. PubMed ID: 29584565
[TBL] [Abstract][Full Text] [Related]
20. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
